Assignee
OVID THERAPEUTICS INC
US·51 granted patents·76 pending applications·246 citations·filing 2015–2025
Top patents by PatentIndex Score
127 records- 0199US11395817B2Methods and compositions for treatment of epileptic disordersOVID THERAPEUTICS INC·Filed 2020·Granted Jul 26, 2022·8 cites·31 claims
- 0299US10799485B2Methods and compositions for treatment of epileptic disordersOVID THERAPEUTICS INC·Filed 2020·Granted Oct 13, 2020·8 cites·20 claims
- 0399US10603308B2Methods and compositions for treatment of epileptic disordersOVID THERAPEUTICS INC·Filed 2019·Granted Mar 31, 2020·17 cites·13 claims
- 0499US9446028B2Methods of increasing tonic inhibition and treating fragile X syndrome and angelman syndromeOVID THERAPEUTICS INC·Filed 2016·Granted Sep 20, 2016·26 cites·8 claims
- 0598US9682069B2Methods of treating Dravet syndromeOVID THERAPEUTICS INC·Filed 2016·Granted Jun 20, 2017·19 cites·7 claims
- 0698US9351968B1Methods of treating developmental disorders using pipradrolOVID THERAPEUTICS INC·Filed 2015·Granted May 31, 2016·24 cites·4 claims
- 0798US9339495B2Methods of increasing tonic inhibition and treating secondary insomniaOVID THERAPEUTICS INC·Filed 2015·Granted May 17, 2016·26 cites·6 claims
- 0897US10363246B1Methods and compositions for treatment of epileptic disordersOVID THERAPEUTICS INC·Filed 2019·Granted Jul 30, 2019·13 cites·5 claims
- 0997US10071083B2Use of gaboxadol in the treatment of tinnitusOVID THERAPEUTICS INC·Filed 2018·Granted Sep 11, 2018·11 cites·15 claims
- 1097US9801864B2Methods of increasing tonic inhibition and treating secondary insomniaOVID THERAPEUTICS INC·Filed 2016·Granted Oct 31, 2017·7 cites·6 claims
- 1197US9744159B2Methods of treatment Rett syndromeOVID THERAPEUTICS INC·Filed 2016·Granted Aug 29, 2017·9 cites·13 claims
- 1296US9717716B2Methods of sedation during critical care treatmentOVID THERAPEUTICS INC·Filed 2016·Granted Aug 1, 2017·16 cites·30 claims
- 1396US9399034B1Methods of sedation during critical care treatmentOVID THERAPEUTICS INC·Filed 2015·Granted Jul 26, 2016·20 cites·10 claims
- 1494US10188635B2Use of gaboxadol in the treatment of tinnitusOVID THERAPEUTICS INC·Filed 2018·Granted Jan 29, 2019·5 cites·15 claims
- 1594US9913833B2Methods of treating developmental disorders using pipradrolOVID THERAPEUTICS INC·Filed 2017·Granted Mar 13, 2018·4 cites·4 claims
- 1693US11291658B2Use of gaboxadol in the treatment of diabetes and related conditionsOVID THERAPEUTICS INC·Filed 2020·Granted Apr 5, 2022·2 cites·16 claims
- 1793US10653652B2Use of (1S,3S)-3-amino-4-(difluoromethylidene) cyclopentane-1-carboxylic acid and (S)-3-amino-4-(difluoromethylenyl)cyclopent-1-ene-1-carboxylic acid in the treatment of tinnitus, acute sensorineural hearing loss, meniere'S disease, tourette'S syndrome, attention deficit hyperactivity disorder and addictionOVID THERAPEUTICS INC·Filed 2019·Granted May 19, 2020·5 cites·7 claims
- 1893US2025025448A1Methods of increasing tonic inhibition and treating secondary insomniaOVID THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1992US2024415817A1Methods and compositions for treatment of epileptic disordersOVID THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2092US2025025449A1Methods and compositions for treatment of epileptic disordersOVID THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2191US10813918B2Use of Gaboxadol in the treatment of diabetes and related conditionsOVID THERAPEUTICS INC·Filed 2018·Granted Oct 27, 2020·3 cites·15 claims
- 2291US9610261B2Methods of treating Prader-Willi SyndromeOVID THERAPEUTICS INC·Filed 2016·Granted Apr 4, 2017·3 cites·10 claims
- 2390US11918563B1Methods and compositions for treatment of epileptic disordersOVID THERAPEUTICS INC·Filed 2023·Granted Mar 5, 2024·0 cites·16 claims
- 2489US11903930B2Methods and compositions for treatment of epileptic disordersOVID THERAPEUTICS INC·Filed 2023·Granted Feb 20, 2024·0 cites·20 claims
- 2589US11806336B2Methods and compositions for treatment of epileptic disordersOVID THERAPEUTICS INC·Filed 2023·Granted Nov 7, 2023·0 cites·41 claims
- 2689US11096929B2Methods of treating developmental disorders with gaboxadolOVID THERAPEUTICS INC·Filed 2018·Granted Aug 24, 2021·3 cites·13 claims
- 2789US10195165B2Methods of treating Prader-Willi syndromeOVID THERAPEUTICS INC·Filed 2017·Granted Feb 5, 2019·2 cites·10 claims
- 2887US10765646B2Methods of treating developmental encephalopathiesOVID THERAPEUTICS INC·Filed 2018·Granted Sep 8, 2020·2 cites·12 claims
- 2987US10111865B2Methods of sedation during critical care treatmentOVID THERAPEUTICS INC·Filed 2017·Granted Oct 30, 2018·2 cites·23 claims
- 3087US9827233B1Methods of treating behavioral syndromes using pipradrolOVID THERAPEUTICS INC·Filed 2017·Granted Nov 28, 2017·4 cites·3 claims
- 3186US12144801B2Methods and compositions for treatment of epileptic disordersOVID THERAPEUTICS INC·Filed 2022·Granted Nov 19, 2024·0 cites·18 claims
- 3285US12465597B2Methods of treating developmental disorders with gaboxadolOVID THERAPEUTICS INC·Filed 2022·Granted Nov 11, 2025·0 cites·1 claims
- 3385US12109201B2Methods and compositions for treatment of epileptic disordersOVID THERAPEUTICS INC·Filed 2022·Granted Oct 8, 2024·0 cites·21 claims
- 3485US2023051859A1Methods of increasing tonic inhibition and treating secondary insomniaOVID THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3584US10870855B2Use of MIR101 or MIR128 in the treatment of seizure disordersOVID THERAPEUTICS INC·Filed 2018·Granted Dec 22, 2020·1 cites·19 claims
- 3684US10704048B2Use of MIR-92A or MIR-145 in the treatment of Angelman syndromeOVID THERAPEUTICS INC·Filed 2019·Granted Jul 7, 2020·1 cites·29 claims
- 3784US10420773B2Methods of treating developmental disorders and/or seizure disorders with etifoxineOVID THERAPEUTICS INC·Filed 2018·Granted Sep 24, 2019·1 cites·8 claims
- 3884US2024173280A1Methods of treating seizure disorders and prader-willi syndromeOVID THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3981US2024252447A1Pharmaceutical formulations containing gaboxadol for therapeutic treatmentOVID THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 4081US2022016091A1Methods of increasing tonic inhibition and treating secondary insomniaOVID THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 4181US2025073214A1Use of gaboxadol for the treatment of non-24 hour sleep-wake disorderOVID THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 4280US2021213000A1Methods and compositions for treatment of epileptic disordersOVID THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 4379US10813899B2Use of (s)-3-amino-4-(difluoromethylenyl) cyclopent-1-ene-l-carboxylic acid and related compounds, (1s,3S)-3-amino-4-(difluoromethylidene) cyclopentane-1-carboxylic acid and vigabatrin in the treatment of developmental disordersOVID THERAPEUTICS INC·Filed 2019·Granted Oct 27, 2020·2 cites·14 claims
- 4479US2023404955A1Use of (1s,3s)-3-amino-4-(difluoromethylidene) cyclopentane-1-carboxylic acid and (s)-3-amino-4-(difluoromethylenyl)cyclopent-1-ene-1-carboxylic acid in the treatment of tinnitus, acute sensorineural hearing loss, meniere’s disease, tourette’s syndrome, attention deficit hyperactivity disorder and addictionOVID THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 4578US12285397B2Use of (s)-3-amino-4-(difluoromethylenyl) cyclopent-1-ene-1-carboxylic acid and related compounds, (1S,3S)-3-amino-4-(difluoromethylidene) cyclopentane-1-carboxylic acid and vigabatrin in the treatment of developmental disordersOVID THERAPEUTICS INC·Filed 2023·Granted Apr 29, 2025·0 cites·17 claims
- 4678US11918551B2Methods of treating seizure disorders and Prader-Willi syndromeOVID THERAPEUTICS INC·Filed 2021·Granted Mar 5, 2024·0 cites·7 claims
- 4778US10765666B2Use of gaboxadol for the treatment of Tourette syndrome, tics and stutteringOVID THERAPEUTICS INC·Filed 2019·Granted Sep 8, 2020·1 cites·20 claims
- 4878US2023285369A1Use of gaboxadol for the treatment of non-24 hour sleep-wake disorderOVID THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 4977US11690829B2Use of gaboxadol for the treatment of non-24 hour sleep-wake disorderOVID THERAPEUTICS INC·Filed 2019·Granted Jul 4, 2023·0 cites·11 claims
- 5077US2019255027A1Methods of treating developmental disorders with gaboxadolOVID THERAPEUTICS INC·Filed 2019·Application pending·0 cites
Showing the top 50 of 127 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when OVID THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →